Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Donald Bergstrom"'
Publikováno v:
BMC Bioinformatics, Vol 21, Iss 1, Pp 1-27 (2020)
Abstract Background Gene expression signatures for the prediction of differential survival of patients undergoing anti-cancer therapies are of great interest because they can be used to prospectively stratify patients entering new clinical trials, or
Externí odkaz:
https://doaj.org/article/4ce95414155744f2978564b39833a92b
Autor:
Borja Catalán-Echeverría, Michael E. Kelly, Lissa Peeling, Donald Bergstrom, Xiongbiao Chen, Mauro Malvè
Publikováno v:
Applied Sciences, Vol 9, Iss 7, p 1341 (2019)
Flow-diverting stents (FDSs) show considerable promise for the treatment of cerebral aneurysms by diverting blood flow away from the aneurysmal sacs, however, post-treatment complications such as failure of occlusion and subarachnoid haemorrhaging re
Externí odkaz:
https://doaj.org/article/c7c6f8b8059947f48f86613801a318dd
Autor:
Mojtaba Nabipoor Hassankiadeh, Jingsi Yang, Mark Berrey, Dave Jordison, Lifeng Zhang, Donald Bergstrom, Raymond J. Spiteri
Publikováno v:
Particuology. 80:103-114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76bc97e2e9b891e0517276a5279ad48e
https://doi.org/10.1016/j.partic.2022.11.014
https://doi.org/10.1016/j.partic.2022.11.014
Autor:
James D. Brenton, Iain A. McNeish, Shah-Jalal Sarker, Evis Sala, Donald Bergstrom, Christine Parkinson, P. David Mozley, Robert Iannone, Raymond Lam, Norbert Avril, Andrea G. Rockall
PDF file - 51KB, Acquisition parameters for PET and CT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13a120d728bd791115be324d32d0f11c
https://doi.org/10.1158/1078-0432.22447908.v1
https://doi.org/10.1158/1078-0432.22447908.v1
Autor:
James D. Brenton, Iain A. McNeish, Shah-Jalal Sarker, Evis Sala, Donald Bergstrom, Christine Parkinson, P. David Mozley, Robert Iannone, Raymond Lam, Norbert Avril, Andrea G. Rockall
PDF file - 36KB, Patient inclusion and exclusion criteria.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f0dc4eb3fcbd54455ecee95064f9b0f
https://doi.org/10.1158/1078-0432.22447911.v1
https://doi.org/10.1158/1078-0432.22447911.v1
Autor:
James D. Brenton, Iain A. McNeish, Shah-Jalal Sarker, Evis Sala, Donald Bergstrom, Christine Parkinson, P. David Mozley, Robert Iannone, Raymond Lam, Norbert Avril, Andrea G. Rockall
Purpose: Repeatability of baseline FDG-PET/CT measurements has not been tested in ovarian cancer. This dual-center, prospective study assessed variation in tumor 2[18F]fluoro-2-deoxy-D-glucose (FDG) uptake, tumor diameter, and tumor volume from seque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::213b424880c73fc4e96d484a4c11d818
https://doi.org/10.1158/1078-0432.c.6521253.v1
https://doi.org/10.1158/1078-0432.c.6521253.v1
Autor:
Virginie Dangles-Marie, Ivan Bièche, Sergio Roman-Roman, Donald Bergstrom, James Watters, Weidong Zhang, Colette Dib, André Nicolas, Sophie Chateau-Joubert, Gerald Massonnet, Louis-Bastien Weiswald, Wulfran Cacheux, Astrid Lièvre, Sophie Richon, Sophie Vacher, Patricia Vrignaud, Manoel Nunes
Genomic alterations in KRAS/BRAF/NRA S wild-type xenografts, according to their response to cetuximab. Tumors were considered to be amplified if the gene copy number was >3. Gene overexpression is defined by an expression superior to average in all P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af225f6671c6799adf3fd8f575ac34ce
https://doi.org/10.1158/0008-5472.22408182
https://doi.org/10.1158/0008-5472.22408182
Autor:
Virginie Dangles-Marie, Ivan Bièche, Sergio Roman-Roman, Donald Bergstrom, James Watters, Weidong Zhang, Colette Dib, André Nicolas, Sophie Chateau-Joubert, Gerald Massonnet, Louis-Bastien Weiswald, Wulfran Cacheux, Astrid Lièvre, Sophie Richon, Sophie Vacher, Patricia Vrignaud, Manoel Nunes
Development of targeted therapeutics required translationally relevant preclinical models with well-characterized cancer genome alterations. Here, by studying 52 colorectal patient-derived tumor xenografts (PDX), we examined key molecular alterations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d084775d867b18b5c5a9bdd7f2ba9561
https://doi.org/10.1158/0008-5472.c.6507480.v1
https://doi.org/10.1158/0008-5472.c.6507480.v1
Autor:
Virginie Dangles-Marie, Ivan Bièche, Sergio Roman-Roman, Donald Bergstrom, James Watters, Weidong Zhang, Colette Dib, André Nicolas, Sophie Chateau-Joubert, Gerald Massonnet, Louis-Bastien Weiswald, Wulfran Cacheux, Astrid Lièvre, Sophie Richon, Sophie Vacher, Patricia Vrignaud, Manoel Nunes
Example of 2 PDXs treated with cetuximab (one red arrow for each injection).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f0aff1f4933f5e44c4757614fc7aa2c
https://doi.org/10.1158/0008-5472.22408188
https://doi.org/10.1158/0008-5472.22408188
Autor:
Ermira Pazolli, Randy Kipp, Alessandro Boezio, Hakan Gunaydin, Amanda Iskandar, Matthew Zubrowski, Bret Williams, Kelley Shortsleeves, Alexandre Larivee, Tom McLean, Klaus Michelsen, Hongtao Zeng, Jonathan LaRochelle, Joe Manna, Lucian DiPietro, Andre Lescarbeau, Mary Mader, Bindu Bennet, Jeremy Wilbur, Qi Wang, Levi Pierce, Iain Martin, James Watters, Pascal Fortin, Donald Bergstrom
Publikováno v:
Cancer Research. 82:P5-16
Inhibition of CDK4/6 combined with the estrogen receptor (ER) degrader fulvestrant significantly improves progression free survival and overall survival in advanced hormone receptor positive (HR+) breast cancer patients and is now the standard of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68ddad78553bc15ede0b650a5dff37d3
https://doi.org/10.1158/1538-7445.sabcs21-p5-16-10
https://doi.org/10.1158/1538-7445.sabcs21-p5-16-10